Systemic Cytokine Release Syndrome Due to SARS-CoV-2 Disease
Showing 1 - 25 of >10,000
Decay, Dental, Missing Teeth, COVID-19 Trial in Ankara, Izmir, Izmir (ELISA test for Cytokines)
Recruiting
- Decay, Dental
- +3 more
- ELISA test for Cytokines
-
Ankara, Turkey
- +3 more
Jul 26, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in
Not yet recruiting
- Systemic Sclerosis
- SARS-CoV 2 Vaccination
- (no location specified)
Jul 24, 2023
EuGeni Rapid Antigen Test for Qualitative Detection of Severe
Terminated
- SARS-CoV-2 Infection
- EuGeni SARS-CoV-2 Antigen Rapid Diagnostic Test
-
Split, Croatia
- +4 more
Jan 3, 2023
Under Invasive Mechanical Ventilation in SARS-CoV-2 &
Not yet recruiting
- ARDS Due to Disease Caused by SARS Co-V-2
- +2 more
- (no location specified)
Feb 1, 2023
MIS-C and Other Complications Following SARS-CoV-2 Infection
Recruiting
- SARS CoV 2 Infection
- +3 more
-
Copenhagen, DenmarkCopenhagen University Hospital Rigshospitalet
Jun 14, 2022
SARS-CoV-2 Acute Respiratory Disease, SARS-CoV2 Infection, Cytokine Storm Trial (Basiliximab Injection, Placebo)
Not yet recruiting
- SARS-CoV-2 Acute Respiratory Disease
- +2 more
- Basiliximab Injection
- Placebo
- (no location specified)
Aug 18, 2021
COVID-19 Vaccine Trial in Ciudad Autónoma de Buenos Aires (ARVAC-CG vaccine (recombinant protein vaccine against SARS-CoV-2))
Active, not recruiting
- COVID-19 Vaccine
- ARVAC-CG vaccine (recombinant protein vaccine against SARS-CoV-2)
-
Ciudad Autónoma de Buenos Aires, ArgentinaUnidad de Investigación Clínica Farmacocinética FP Clinical Phar
Dec 21, 2022
Covid19, Hypertension, Corona Persistent Symptoms Trial in Giza (Inspiratory muscle trainer, diaphragmatic release)
Enrolling by invitation
- Covid19
- +2 more
- Inspiratory muscle trainer
- diaphragmatic release
-
Giza, Dokki, EgyptFaculty of Physical Therapy
Jun 17, 2022
SARS (Severe Acute Respiratory Syndrome), Cytokine Storm, ARDS, Human Trial in Germany, Sweden (Hyperbaric oxygen)
Terminated
- SARS (Severe Acute Respiratory Syndrome)
- +5 more
- Hyperbaric oxygen
-
Regensburg, Germany
- +2 more
Jan 5, 2023
SARS-CoV-2 Lifestyle Changes on Non-alcoholic Fatty Liver
Completed
- Non-Alcoholic Fatty Liver Disease
- SUPERIMPOSED SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 (SARS-CoV-2) LIFESTYLE CHANGES
-
Naples, ItalyUniversity of Campania "Luigi Vanvitelli"
Jun 9, 2022
MISC COVID-19 Study in Pediatric Population
Recruiting
- SARS-CoV2 Infection
- Multisystem Inflammatory Syndrome in Children
-
Chennai, Tamilnadu, IndiaNational Institute for Research in Tuberculosis
Jul 7, 2022
The Clinical Manifestations of Severe Acute Respiratory
Completed
- Covid19
-
Assiut, EgyptAssiut University Hospital
Jun 5, 2022
SARS-CoV-2 Longitudinal Study: Understanding Susceptibility,
Recruiting
- SARS-CoV Infection
-
London, United Kingdom
- +2 more
May 20, 2022
Sars-CoV2, Acute Respiratory Distress Syndrome, COVID-19 Trial in Houston (Mesenchymal Stromal Cells, Supportive Care)
Recruiting
- Sars-CoV2
- +2 more
- Mesenchymal Stromal Cells
- Supportive Care
-
Houston, TexasHouston Methodist Hospital
Dec 19, 2022
Plasma SARS-CoV-2 RNA Levels in Critically Ill COVID-19 Patients
Not yet recruiting
- COVID-19 Pneumonia
- ARDS Due to Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2
- plasmatic SARS-CoV-2 RNA quantification
- (no location specified)
Nov 9, 2021
Severe Acute Respiratory Syndrome-related Coronavirus, Renal Dialysis, Vaccines Trial in Chongqing (drug, diagnostic test,
Completed
- Severe Acute Respiratory Syndrome-related Coronavirus
- +4 more
- Nifedipine 30 MG
- +10 more
-
Chongqing, Chongqing, ChinaResidential Address
Feb 1, 2023
COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and
Active, not recruiting
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- +2 more
- SARS-CoV-2 and/or MIS-C Exposure
-
Loma Linda, California
- +19 more
Sep 22, 2022
Severe Acute Respiratory Syndrome-2/COVID-19 in Children
Active, not recruiting
- COVID-19
- +2 more
-
Hartford, ConnecticutConnecticut Children's Medical Center
Apr 14, 2022
Covid19, SARS-CoV Infection Trial in Seattle (Zinc Picolinate, Resveratrol, Zinc Picolinate Placebo)
Terminated
- Covid19
- SARS-CoV Infection
- Zinc Picolinate
- +3 more
-
Seattle, WashingtonSwedish Medical Center
Jul 26, 2022
Respiratory Viral Infection, Common Cold, Severe Acute Respiratory Syndrome (SARS) Pneumonia Trial in Vienna (nasal spray)
Completed
- Respiratory Viral Infection
- +4 more
- nasal spray
-
Vienna, Austria
- +1 more
Aug 24, 2022
RECOVAC - Long Term Efficacy and Safety of COVID-19 Vaccination
Active, not recruiting
- Covid19
- +2 more
- mailer-based finger-prick
-
Groningen, NetherlandsUniversity Medical Center Groningen
Mar 14, 2022
Cytokine Storm, SARS-CoV-2 Trial in Philadelphia (Doxycycline, Placebo)
Withdrawn
- Cytokine Storm
- SARS-CoV-2
- Doxycycline
- Placebo
-
Philadelphia, PennsylvaniaTemple University Hospital
Apr 13, 2021
Hypoxia, SARS-CoV-2 Acute Respiratory Disease, Carotid Bodies Trial in Chicago (Phase-1: Breath Holding Test, Phase 2: 6-Minute
Completed
- Hypoxia
- +2 more
- Phase-1: Breath Holding Test
- Phase 2: 6-Minute Walk Test (6MWT)
-
Chicago, IllinoisUniversity of Chicago Medical Center
Apr 26, 2022
NeuMoDx™ FluA/FluB/RSV/Severe Acute Respiratory Syndrome-CoV-2
Recruiting
- Respiratory Disease
- NeuMoDx™ FluA/FluB/RSV/SARS-CoV-2 Assay
-
Manchester, United KingdomQIAGEN Gaithersburg, Inc
Apr 1, 2022